• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Corcept Therapeutics Incorporated - Common Stock (NQ:CORT)

    40.04 +0.41 (+1.03%)
    Streaming Delayed Price Updated: 12:32 PM EST, Feb 18, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 253,426
    Open 39.48
    Bid (Size) 40.04 (100)
    Ask (Size) 40.08 (200)
    Prev. Close 39.63
    Today's Range 39.15 - 40.51
    52wk Range 32.99 - 117.33
    Shares Outstanding 115,926,629
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2025 Financial Results, Provide Corporate Update and Host Conference Call
    From Corcept Therapeutics Incorporated
    Via Business Wire
    News headline image
    CORT SECURITIES INVESTIGATION: Kaplan Fox Reminds Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Potential Securities Law Violations
    NEW YORK, NY - February 17, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Corcept Therapeutics, Inc. (“Corcept” or the “Company”) (NASDAQ:... 
    Via TheNewswire.com

    Performance

    YTD
    +4.8%
    +4.8%
    1 Month
    +13.5%
    +13.5%
    3 Month
    -46.7%
    -46.7%
    6 Month
    -43.0%
    -43.0%
    1 Year
    -44.8%
    -44.8%

    More News

    Read More
    News headline image
    CORT SECURITIES INVESTIGATION: Kaplan Fox Reminds Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Potential Securities Law Violations
    Via NewMediaWire
    News headline image
    CORCEPT THERAPEUTICS INCORPORATED (NASDAQ: CORT) INVESTIGATION ALERT: Bernstein Liebhard is Investigating Possible Securities Claims against Corcept Therapeutics Incorporated
    From Bernstein Liebhard LLP
    Via GlobeNewswire
    Corcept Therapeutics Inc (NASDAQ:CORT) Presents a Compelling GARP Investment Case ↗
    Via Chartmill
    News headline image
    3 Small-Cap Stocks We Think Twice About
    Via StockStory
    News headline image
    3 Cash-Producing Stocks We’re Skeptical Of
    Via StockStory
    News headline image
    CORCEPT THERAPEUTICS SECURITIES INVESTIGATION: Kaplan Fox Alerts Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Possible Securities Law Violations
    Via NewMediaWire
    News headline image
    CORCEPT THERAPEUTICS SECURITIES INVESTIGATION: Kaplan Fox Alerts Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Possible Securities Law Violations
    Via TheNewswire.com
    News headline image
    Inspire Medical Systems, Astrana Health, Evolent Health, Corcept, and Centene Stocks Trade Up, What You Need To Know
    Via StockStory
    Topics Economy
    News headline image
    CORT INVESTIGATION REMINDER: Corcept Therapeutics Faces Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP
    Via NewMediaWire
    News headline image
    CORT INVESTIGATION REMINDER: Corcept Therapeutics Faces Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP
    Via TheNewswire.com
    News headline image
    CORCEPT THERAPEUTICS INCORPORATED (NASDAQ: CORT) INVESTIGATION ALERT: Bernstein Liebhard is Investigating Possible Securities Claims against Corcept Therapeutics Incorporated
    From Bernstein Liebhard LLP
    Via GlobeNewswire
    News headline image
    CORCEPT THERAPEUTICS Investors Are Encouraged to Contact Kaplan Fox & Kilsheimer LLP Regarding Potential Securities Law Violations
    Via NewMediaWire
    News headline image
    CORCEPT THERAPEUTICS Investors Are Encouraged to Contact Kaplan Fox & Kilsheimer LLP Regarding Potential Securities Law Violations
    Via TheNewswire.com
    News headline image
    CORCEPT THERAPEUTICS INVESTIGATION ALERT: Corcept Therapeutics Faces Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP
    Via NewMediaWire
    News headline image
    CORCEPT THERAPEUTICS INVESTIGATION ALERT: Corcept Therapeutics Faces Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP
    Via TheNewswire.com
    News headline image
    CORCEPT THERAPEUTICS INCORPORATED (NASDAQ: CORT) INVESTIGATION ALERT: Bernstein Liebhard is Investigating Possible Securities Claims against Corcept Therapeutics Incorporated
    From Bernstein Liebhard LLP
    Via GlobeNewswire
    News headline image
    CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    CORT SECURITIES INVESTIGATION: Kaplan Fox is Investigating Possible Securities Violations Against Corcept Therapeutics, Inc. (CORT)
    Via NewMediaWire
    News headline image
    CORT SECURITIES INVESTIGATION: Kaplan Fox is Investigating Possible Securities Violations Against Corcept Therapeutics, Inc. (CORT)
    Via TheNewswire.com
    News headline image
    CORCEPT THERAPEUTICS Is Being Investigated for Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP
    Via NewMediaWire
    News headline image
    CORCEPT THERAPEUTICS Is Being Investigated for Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP
    Via TheNewswire.com
    News headline image
    CORCEPT THERAPEUTICS SECURITIES INVESTIGATION: Kaplan Fox & Kilsheimer LLP is Investigating Corcept Therapeutics, Inc. (CORT) for Possible Securities Law Violations
    Via NewMediaWire
    News headline image
    CORCEPT THERAPEUTICS SECURITIES INVESTIGATION: Kaplan Fox & Kilsheimer LLP is Investigating Corcept Therapeutics, Inc. (CORT) for Possible Securities Law Violations
    Via TheNewswire.com

    Frequently Asked Questions

    Is Corcept Therapeutics Incorporated - Common Stock publicly traded?
    Yes, Corcept Therapeutics Incorporated - Common Stock is publicly traded.
    What exchange does Corcept Therapeutics Incorporated - Common Stock trade on?
    Corcept Therapeutics Incorporated - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Corcept Therapeutics Incorporated - Common Stock?
    The ticker symbol for Corcept Therapeutics Incorporated - Common Stock is CORT on the Nasdaq Stock Market
    What is the current price of Corcept Therapeutics Incorporated - Common Stock?
    The current price of Corcept Therapeutics Incorporated - Common Stock is 40.04
    When was Corcept Therapeutics Incorporated - Common Stock last traded?
    The last trade of Corcept Therapeutics Incorporated - Common Stock was at 02/18/26 12:32 PM ET
    What is the market capitalization of Corcept Therapeutics Incorporated - Common Stock?
    The market capitalization of Corcept Therapeutics Incorporated - Common Stock is 4.64B
    How many shares of Corcept Therapeutics Incorporated - Common Stock are outstanding?
    Corcept Therapeutics Incorporated - Common Stock has 5B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.